Background
Takeda is a global biopharmaceutical company originating from Japan and currently operating in over 80 countries around the world. The company’s annual revenue in 2022 exceeded 4 billion yen. Takeda focuses its activities on drugs used to treat diseases related to the digestive system, oncology, neurological diseases, and plasma-based therapies. Additionally, the company is committed to developing new treatment methods in the areas of immunology, hematology, and metabolic disorders.
The implementation project described in this case study pertained to the Polish branch of the Takeda concern. Given its scale and the specificity of the industry, the company is involved in multi-million tenders. The documentation accompanying these processes is often extensive, characterized by complex formulations and difficult terminology. Consequently, analyzing all documentation and managing further information throughout the tender presents numerous challenges.